Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer.

Zhuo C, Xun Z, Hou W, Ji F, Lin X, Tian H, Zheng W, Chen M, Liu C, Wang W, Chen C.

Front Pharmacol. 2019 Oct 22;10:1262. doi: 10.3389/fphar.2019.01262. eCollection 2019. Review.


Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.


Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.


Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.

Millan MJ, Goodwin GM, Meyer-Lindenberg A, Ove Ögren S.

Eur Neuropsychopharmacol. 2015 May;25(5):599-656. doi: 10.1016/j.euroneuro.2015.01.016. Epub 2015 Feb 7. Review.



Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.


Repurposing existing agents as adjunct therapies for glioblastoma.

Purow B.

Neurooncol Pract. 2016 Sep;3(3):154-163. doi: 10.1093/nop/npv041. Epub 2015 Sep 30.


Drug repurposing for the treatment of glioblastoma multiforme.

Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD, Paggi MG.

J Exp Clin Cancer Res. 2017 Nov 28;36(1):169. doi: 10.1186/s13046-017-0642-x. Review.


Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.

Nestsiarovich A, Mazurie AJ, Hurwitz NG, Kerner B, Nelson SJ, Crisanti AS, Tohen M, Krall RL, Perkins DJ, Lambert CG.

Bipolar Disord. 2018 Dec;20(8):761-771. doi: 10.1111/bdi.12665. Epub 2018 Jun 19.


Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.

Mottini C, Napolitano F, Li Z, Gao X, Cardone L.

Semin Cancer Biol. 2019 Sep 25. pii: S1044-579X(19)30139-7. doi: 10.1016/j.semcancer.2019.09.023. [Epub ahead of print] Review.


[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].

Munch G, Godart N.

Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18. Review. French.


Precision medicine for suicidality: from universality to subtypes and personalization.

Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, Kurian SM, Shekhar A, Schork NJ, Sandusky GE, Salomon DR.

Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.


Novel drugs and therapeutic targets for severe mood disorders.

Mathew SJ, Manji HK, Charney DS.

Neuropsychopharmacology. 2008 Aug;33(9):2080-92. doi: 10.1038/sj.npp.1301652. Epub 2008 Jan 2. Review. Erratum in: Neuropsychopharmacology. 2008 Aug;33(9):2300.


Cognitive deficits in bipolar disorders: Implications for emotion.

Lima IMM, Peckham AD, Johnson SL.

Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Review.


[Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].

Ampélas JF, Wattiaux MJ, Van Amerongen AP.

Encephale. 2001 Nov-Dec;27(6):588-99. French.


The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.


For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.

Mark TL.

CNS Drugs. 2010 Apr;24(4):319-26. doi: 10.2165/11533120-000000000-00000.


Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?

Lagace DC, Eisch AJ.

Psychiatr Clin North Am. 2005 Jun;28(2):399-414. Review.


Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, Vanipenta NP, Khan FN, Mullen J, Shankar G, Cook S, Humbert C, Ballew A, Yard M, Gelbart T, Shekhar A, Schork NJ, Kurian SM, Sandusky GE, Salomon DR.

Mol Psychiatry. 2015 Nov;20(11):1266-85. doi: 10.1038/mp.2015.112. Epub 2015 Aug 18.

Supplemental Content

Support Center